Recombinant Human PSA Protein，His

Phosphatidylserine (PSA) is a phospholipid component of cell membranes that plays a crucial role in cellular signaling, apoptosis, and immune responses. In recent years, the research on PSA and its recombinant proteins has gained significant attention due to their potential applications in both therapeutic and diagnostic fields. Recombinant PSA proteins are engineered to enhance their functional properties, allowing for greater specificity and efficacy in various biomedical applications. Researchers are investigating their roles in cancer therapy, where PSA can be utilized as a target for immuno-oncology approaches, enabling the development of more effective cancer vaccines and targeted therapies. Additionally, PSA's ability to modulate immune responses has spurred interest in its use for autoimmune diseases and inflammatory conditions. By utilizing advanced techniques such as genetic engineering and protein expression systems, scientists can produce large quantities of purified PSA proteins, facilitating detailed studies on their structural and functional characteristics. This research not only aims to elucidate the underlying mechanisms of PSA in cellular processes but also seeks to explore novel therapeutic strategies, thus advancing our understanding of its potential as a biomarker and therapeutic target in diverse medical conditions. As the field progresses, the continued exploration of recombinant PSA proteins offers promising avenues for innovative treatment modalities and enhances our capability to tackle complex diseases.